Adrestia Therapeutics Partners with Patient Advocacy Groups to Further A-T Research
The A-T Children's Project is excited to be part of this A-T research initiative. Please see the following press release from Adrestia Therapeutics: Read More
The A-T Children's Project is excited to be part of this A-T research initiative. Please see the following press release from Adrestia Therapeutics: Read More
A year has passed since the launch of the Global A-T Family Data Platform, an effort overseen by A-T families to enable researchers and clinicians to mine large data sets and gain new insights about ataxia-telangiectasia. So far, A-T families from 19 countries have contributed health information about their children who have A-T. The platform’s … Read More
Two of our long time scientific advisors have been elected to the prestigious National Academy of Sciences, one of the highest honors bestowed upon research scientists. Nathaniel Heintz, PhD Nathaniel (Nat) Heintz is the James and Marilyn Simons Professor and head of the Laboratory of Molecular Biology at The Rockefeller University in New York. Dr. … Read More
Families will contribute their data using on-line family questionnaires, whole-genome sequencing and other approaches, serving as a model for other diseases Families around the world who have children affected by ataxia-telangiectasia (A-T) today announced the launch of the Global A-T Family Data Platform, through which health, genomic and potentially other types of data about their … Read More
Scientists and clinicians from around the world traveled to Beijing, China in October to share information at the 2015 A-T Workshop, a meeting co-sponsored by the A-T Children’s Project and held at the Capital Normal University. Beyond primarily discussing DNA repair roles of the ATM protein as in the past, this year’s meeting included sessions … Read More
Press Release from Recursion Pharmaceuticals Salt Lake City – Recursion Pharmaceuticals, an emerging biotech company today announced receipt of a research award from the A-T Children’s Project, which seeks to support research for the disease ataxia-telangiectasia. Ataxia-telangiectasia (A-T) is a rare genetic disease that attacks children, causing progressive loss of muscle control, immune system problems, … Read More
From the Sanford-Burnham Medical Research Institute Press Release: Researchers discover mutations in a protein that plays a role in the body’s DNA repair system—similar to what’s observed in the rare children’s disease ataxia-telangiectasia. The discovery provides an approach to identifying therapies that will resuscitate the broken DNA repair mechanism. Newswise — LA JOLLA, Calif., March … Read More
IN HONOR OF OUR FRIEND JOE Read More